Vtgn stock forecast.
Future criteria checks 2/6. Vistagen Therapeutics's earnings are forecast to decline at 12.9% per annum while its annual revenue is expected to grow at 80.5% per year. EPS is expected to grow by 30.5% per annum.
Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.For VistaGen Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average VistaGen Therapeutics stock forecast of $4.98, a high forecast of $6.23, and a low forecast of $3.42. The average VistaGen Therapeutics stock forecast 2031 represents a 44.91% increase from the last price of $3.44000005722046.About Us Committed to developing a new generation of CNS medicines that go beyond the current standard of care. Vistagen is developing an innovative pipeline of Central Nervous System (CNS) medications with the potential to establish new standards of care in the treatment of a variety of serious anxiety, depression and other CNS disorders that are …VTGN Earnings Forecast. Next quarter’s earnings estimate for VTGN is -$0.68 with a range of -$0.68 to -$0.68. The previous quarter’s EPS was -$0.94. VTGN beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.55% of the time in the same period.For comparison, the stock’s daily average trading volume is about 1.2 million shares. VTGN is down 85.3% as of Friday afternoon. There’s more recent stock market news to check out below!
6 brokers have issued 1 year price objectives for Olema Pharmaceuticals' shares. Their OLMA share price targets range from $18.00 to $28.00. On average, they predict the company's stock price to reach $21.20 in the next year. This suggests a possible upside of 45.4% from the stock's current price.Based on analysts offering 12 month price targets for VTGN in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Track VistaGen Therapeutics Inc (VTGN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
Vertex Energy Stock Forecast, VTNR stock price prediction. The best long-term & short-term Vertex Energy share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 ...
VTGN Earnings Forecast. Next quarter’s earnings estimate for VTGN is -$0.68 with a range of -$0.68 to -$0.68. The previous quarter’s EPS was -$0.94. VTGN beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.55% of the time in the same period. Back to VTGN Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.VTGN has an Altman Z-Score of -5.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for VistaGen Therapeutics, Inc. (VTGN) stock, including valuation metrics, financial numbers, share information and more.About Vistagen. Board of Directors. Advisory Board. Our Purpose, Our Vision. Diversity & Inclusion. Pipeline Overview. Fasedienol (PH94B) Itruvone (PH10) AV-101.
The following two healthcare stocks and one consumer stock have what it takes to produce lasting revenue growth in the coming five years -- and eventually, major share-price gains. That means they ...
Vistagen Therapeutics Inc. 3.18. Delayed Data. As of 3:59pm ET. +0.45 / +16.48%. Today’s Change. 1.62. Today ||| 52-Week Range. 24.71.
Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. Vertex Energy Inc () Stock Market info Recommendations: Buy or sell Vertex Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vertex Energy share forecasts, stock quote and buy / sell signals below.According to present data Vertex Energy's VTNR shares and potentially its market environment have …See Vistagen Therapeutics, Inc. (VTGN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Nov 9, 2023 · MT. Maxim Cuts Price Target on VistaGen Therapeutics to $12 From $30, Maintains Buy Rating. Oct. 17. MT. Maxim Downgrades VistaGen Therapeutics to Hold From Buy. 2022. MT. Jefferies Downgrades VistaGen Therapeutics to Hold from Buy, Adjusts Price Target to $0.20 from $8. Nov 28, 2023 · Stock analysis for Vistagen Therapeutics Inc (VTGN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. What this means: InvestorsObserver gives Vistagen Therapeutics Inc. (VTGN) an overall rank of 48, which is below average. Vistagen Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 48 means that 52% of stocks appear more favorable to our system.
Find real-time OTLK - Outlook Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 17, 2023 · VistaGen Therapeutics Stock Forecast and Price Target. The average target price set lately by experts for VistaGen Therapeutics to reach by the end of the year is $8.50, which would imply a potential upside of approximately 156.02 percent from the previous closing price if it were to be achieved. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jun. 6, 2023-- Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced that it will implement a …Vertex Energy Inc () Stock Market info Recommendations: Buy or sell Vertex Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vertex Energy share forecasts, stock quote and buy / sell signals below.According to present data Vertex Energy's VTNR shares and potentially its market environment have …... Stock 12 Months Forecast. Based on 17 Wall Street analysts offering 12 month ... (VTGN) Stock Price, Quote, latest community messages, chart, news and other ...Ventas, Inc. (VTR) share price prediction for 2023, 2024, 2025, 2026 and 2027. VTR one year forecast. Vitura stock monthly and weekly forecasts.
Get the latest Internet Infinity Inc (ITNF) real-time quote, historical performance, charts, and other financial information to help you make more informed ...
Vistagen (NASDAQ:VTGN) is a late-stage biopharmaceutical firm. Vistagen is best known for working on treatments to transform the way people living with depression, anxiety, and other CNS issues ...For VistaGen Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average VistaGen Therapeutics stock forecast of $4.98, a high forecast of $6.23, and a low forecast of $3.42. The average VistaGen Therapeutics stock forecast 2031 represents a 44.91% increase from the last price of $3.44000005722046.About the VistaGen Therapeutics, Inc. stock forecast. As of 2023 November 29, Wednesday current price of VTGN stock is 3.600$ and our data indicates that the …Vertex Energy Stock Forecast, VTNR stock price prediction. The best long-term & short-term Vertex Energy share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 ... Nov 7, 2023 · VTGN Stock Shows Promising Signs for Investors with Potential for Significant Growth. VTGN stock performances on November 7, 2023, showed promising signs for investors. According to data from CNN Money, the 12-month price forecasts for Vistagen Therapeutics Inc had a median target of $12.00, with both the high and low estimates also at $12.00. Nov 27, 2023 · VTGN has an Altman Z-Score of -5.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for VistaGen Therapeutics, Inc. (VTGN) stock, including valuation metrics, financial numbers, share information and more. The 2 analysts offering 1 year price forecasts for VTGN have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock ratings to VTGN in the past 3 months. The 2 analysts offering 1 year price forecasts for VTGN have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock ratings to VTGN in the past 3 months.The stock price for . Vistagen Therapeutics (NASDAQ: VTGN) is $3.8 last updated Today at November 30, 2023 at 2:28 PM UTC. Q Does Vistagen Therapeutics (VTGN) pay a dividend?
The following two healthcare stocks and one consumer stock have what it takes to produce lasting revenue growth in the coming five years -- and eventually, major share-price gains. That means they ...
According to our current VTGN stock forecast, the value of VistaGen Therapeutics shares will drop by -6.38% and reach $ 3.46 per share by December 5, 2023. According to our …
Nov 28, 2023 · Stock analysis for Vistagen Therapeutics Inc (VTGN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock prices follow Earnings Per Share, which are trending downward. 2015 2017 2019 2021. Biotech. ... VTGN is a good value when compared to its 3-year average PE Ratio. 2015 2017 2019 2021.SOUTH SAN FRANCISCO, Calif., August 07, 2023--Vistagen (NASDAQ: VTGN), a clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety ...Track NeuBase Therapeutics Inc (NBSE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe Amesite Inc. stock price fell by -0.518% on the last day (Wednesday, 29th Nov 2023) from $1.93 to $1.92. During the last trading day the stock fluctuated 5.73% from a day low at $1.92 to a day high of $2.03. The price has fallen in 8 of the last 10 days and is down by -9.22% for this period. Volume fell on the last day along with the stock ...Find real-time MCOM - micromobility.com inc stock quotes, company profile, news and forecasts from CNN Business.33. Shawn Singh. https://www.vistagen.com. Vistagen Therapeutics, Inc., a late clinical-stage biopharmaceutical company, primarily focus to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders. The company’s pipeline includes six clinical stage product candidates ..."Phase 3 topline results due in 2H 2023." This is one of three upcoming announcements for the company. VistaGen Therapeutics inched up $0.0018 (+1.29%) to $0.14 ...Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.According to our current VTGN stock forecast, the value of VistaGen Therapeutics shares will drop by -6.38% and reach $ 3.46 per share by December 5, 2023. According to our …Passion and purpose to transform patient journeys in anxiety and depression. VistaGen Therapeutics' is developing an innovative pipeline of Central Nervous System medications with the potential to establish new standards of care, safety, and effectiveness in the treatment of a variety of serious anxiety, depression and other CNS disorders.
Right now Maxim Group has a Buy rating on the stock along with a $5 price target. This puts Maxim’s VTGN stock forecast roughly 233% higher than Tuesday’s closing price. Similar to SeaChange, a lot of the momentum has come in December. In fact, since the start of the month, VTGN stock has climbed over 90%.VistaGen Therapeutics, Inc. VTGNNASDAQ VTGNNASDAQ 3.69USD −0.03 −0.81% Last update at Nov 29, 16:27 UTC-8 3.80USD +0.11 +2.98% Pre-Market. Last update at 06:28 …... VTGN, WATT, WCC, WMT, WRAP, XNET, YNDX, ZBRA, ZM, ZNGA. References. Malkiel, B.G.; Fama, E.F. Efficient capital markets: A review of theory and empirical ...VistaGen Therapeutics Stock Forecast and Price Target The average target price set lately by experts for VistaGen Therapeutics to reach by the end of the year is …Instagram:https://instagram. penny tech stocksexpensive stocksempire financial researchboxx etf KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com virtual insurance companiess and p 500 dividend yield Track Mullen Automotive Inc (MULN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsData Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ... berners by good day farm The SEC requires all publicly traded companies, foreign and domestic, to disclose financial condition, operating results, management compensation, and other areas of their business on a regular ...Find the latest Bionomics Limited (BNOX) stock quote, history, news and other vital information to help you with your stock trading and investing.